Alternate Day Buprenorphine Administration, Phase X - 15

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to determine how subjects will make changes in the amount of medication received when given a monetary alternative to buprenorphine.

Key facts

Study ID

NCT00000233

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1993-05-01

Last updated by the study team

2005-08-17

Who can join

Age: 34 and older, up to 51. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.